2021 Form 10-K Financial Statement
#000149315222008184 Filed on March 30, 2022
Income Statement
Concept | 2021 | 2020 |
---|---|---|
Revenue | $46.00K | $77.00K |
YoY Change | -40.26% | -40.77% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $25.62M | $1.952M |
YoY Change | 1212.58% | -71.46% |
% of Gross Profit | ||
Research & Development | $729.1K | $876.8K |
YoY Change | -16.85% | -49.09% |
% of Gross Profit | ||
Depreciation & Amortization | $89.11K | $121.4K |
YoY Change | -26.59% | -44.16% |
% of Gross Profit | ||
Operating Expenses | $26.35M | $2.829M |
YoY Change | 831.54% | -66.96% |
Operating Profit | -$26.31M | |
YoY Change | ||
Interest Expense | -$1.815M | -$3.781M |
YoY Change | -51.99% | -13.08% |
% of Operating Profit | ||
Other Income/Expense, Net | -$18.00M | |
YoY Change | ||
Pretax Income | -$44.30M | -$11.27M |
YoY Change | 293.01% | -23.04% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$44.30M | -$11.27M |
YoY Change | 293.01% | -23.04% |
Net Earnings / Revenue | -96311.52% | -14639.86% |
Basic Earnings Per Share | -$37.30 | |
Diluted Earnings Per Share | -$37.30M | -$28.56M |
COMMON SHARES | ||
Basic Shares Outstanding | 1.188M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 | 2020 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $21.03M | $3.065M |
YoY Change | 586.11% | 184515.06% |
Cash & Equivalents | ||
Short-Term Investments | ||
Other Short-Term Assets | $436.2K | $105.4K |
YoY Change | 313.79% | 199.46% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $5.000K | $17.00K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $21.47M | $3.187M |
YoY Change | 573.6% | 4528.26% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $395.8K | $495.8K |
YoY Change | -20.16% | -24.69% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $985.5K | $1.160M |
YoY Change | -15.04% | -16.99% |
TOTAL ASSETS | ||
Total Short-Term Assets | $21.47M | $3.187M |
Total Long-Term Assets | $985.5K | $1.160M |
Total Assets | $22.45M | $4.347M |
YoY Change | 416.52% | 196.46% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $50.83K | $118.9K |
YoY Change | -57.23% | -93.92% |
Accrued Expenses | $254.0K | $925.9K |
YoY Change | -72.57% | -74.92% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $58.97K | $0.00 |
YoY Change | -100.0% | |
Total Short-Term Liabilities | $363.8K | $1.045M |
YoY Change | -65.18% | -92.39% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $191.0K | $4.270M |
YoY Change | -95.53% | |
Other Long-Term Liabilities | $301.7K | $363.5K |
YoY Change | -17.02% | -30.35% |
Total Long-Term Liabilities | $492.7K | $4.634M |
YoY Change | -89.37% | 787.88% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $363.8K | $1.045M |
Total Long-Term Liabilities | $492.7K | $4.634M |
Total Liabilities | $856.5K | $5.679M |
YoY Change | -84.92% | -60.13% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $21.60M | -$1.331M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $22.45M | $4.347M |
YoY Change | 416.52% | 196.46% |
Cashflow Statement
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020 | BRTX |
Shares Issued In Cashless Exercise Of Warrants
SharesIssuedInCashlessExerciseOfWarrants
|
USD | |
CY2021 | us-gaap |
Accretion Expense
AccretionExpense
|
USD | |
CY2021 | BRTX |
Reorganization Items Net
ReorganizationItemsNet
|
USD | |
CY2021 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
USD | |
CY2020 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
USD | |
CY2020 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
USD | |
CY2020Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
USD | |
CY2021Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
USD | |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
USD | |
CY2020Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
USD | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
CY2021 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
USD | |
CY2021 | us-gaap |
Reorganization Items
ReorganizationItems
|
USD | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
CY2020 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
USD | |
CY2021 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
USD | |
CY2020 | BRTX |
Proceeds From Ppp Loan
ProceedsFromPppLoan
|
USD | |
CY2021 | BRTX |
Proceeds From Debtor In Possession Financing
ProceedsFromDebtorInPossessionFinancing
|
USD | |
CY2021 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
USD | |
CY2021 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
USD | |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
CY2020 | BRTX |
Noncash Accrued Expense Exchanged For Converitble Notes
NoncashAccruedExpenseExchangedForConveritbleNotes
|
USD | |
CY2021 | BRTX |
Shares Issued In Satisfaction Of Bankruptcy Allowable Claims
SharesIssuedInSatisfactionOfBankruptcyAllowableClaims
|
USD | |
CY2021 | BRTX |
Fair Market Value Of Benefical Conversion Feature And Warrants Issued Convertible Notes Payable Instruments
FairMarketValueOfBeneficalConversionFeatureAndWarrantsIssuedConvertibleNotesPayableInstruments
|
USD | |
CY2021 | BRTX |
Sale Of Warrants Recorded As Derivative Liabilities
SaleOfWarrantsRecordedAsDerivativeLiabilities
|
USD | |
CY2020 | BRTX |
Converitble Debt And Accrued Interest Exchanged For Common And Preferred Shares And Warrants In Public Offering
ConveritbleDebtAndAccruedInterestExchangedForCommonAndPreferredSharesAndWarrantsInPublicOffering
|
USD | |
CY2020 | BRTX |
Accrued Dip Expenses Exchanged For Convertible Notes
AccruedDipExpensesExchangedForConvertibleNotes
|
USD | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
|
USD | |
CY2020Q4 | BRTX |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
USD | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
USD | |
CY2020 | BRTX |
Thirdparty Purchases
ThirdpartyPurchases
|
USD | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
CY2020 | BRTX |
Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue
|
USD | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
USD | |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
CY2020Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
USD | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
USD | |
CY2020 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
USD | |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
USD | |
CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
USD | |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
USD | |
CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
USD | |
CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
USD | |
CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
USD | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure | |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure | |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
657598 | USD |